Literature DB >> 9517870

Prevalence, awareness, treatment, and control of hypertension in a Spanish population.

A Puras1, C Sanchis, L M Artigao, J A Divison.   

Abstract

A cross-sectional population survey using a random, stratified sample into phases was conducted in order to assess the prevalence, awareness, treatment, and control of hypertension in Albacete (a south-eastern province in Spain) with 248000 inhabitants over 18 years of age. The sample size was of 1322 people. Both systolic and diastolic BP were higher in men than in women and showed an increasing trend with age independently of gender. Assuming a cut-off for hypertension of <140/90 mm Hg and <160/95 mm Hg, we found a prevalence of hypertension of 32.7% and 23.1%, respectively. Overall, 56.5% of hypertensive subjects were aware of their condition. The degree of this awareness was significantly higher in women and in the elderly. The percentage of patients who were receiving antihypertensive treatment was 49.1%. This proportion was also higher among women, elderly people, and subjects living in urban areas. High BP was successfully controlled in 10.9% of the total hypertensive population which accounted for 24.4% of the treated patients. The corresponding figures for the <160/95 mm Hg cut-off were 38.5% and 60.6%, respectively. In the logistic regression model, male gender and size of the local community were significantly associated with a better pharmacological control of hypertension. We found a high prevalence of hypertension with low degree of awareness and control, despite the general progress made in the diagnosis and treatment of hypertension in Spain. Specific intervention programs are necessary to increase the extent of control of hypertension in our country.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517870     DOI: 10.1023/a:1007483916158

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  14 in total

1.  Epidemiology of hypertension in Europe.

Authors:  F Magrini; P Reggiani
Journal:  Eur Heart J       Date:  1992-12       Impact factor: 29.983

2.  Progress in the battle against hypertension. Changes in blood pressure levels in the United States from 1960 to 1980.

Authors:  A L Dannenberg; T Drizd; M J Horan; S G Haynes; P E Leaverton
Journal:  Hypertension       Date:  1987-08       Impact factor: 10.190

3.  Current status of hypertension control in an industrial population.

Authors:  J A Schoenberger; J Stamler; R B Shekelle; S Shekelle
Journal:  JAMA       Date:  1972-10-30       Impact factor: 56.272

4.  Plan and operation of the Second National Health and Nutrition Examination Survey, 1976-1980.

Authors:  A McDowell; A Engel; J T Massey; K Maurer
Journal:  Vital Health Stat 1       Date:  1981

5.  Hypertension prevalence, awareness, treatment, and control among African Americans in the 1990s: estimates from the Maywood Cardiovascular Survey.

Authors:  V Freeman; C Rotimi; R Cooper
Journal:  Am J Prev Med       Date:  1996 May-Jun       Impact factor: 5.043

6.  Evaluation of an electronic blood pressure device for epidemiological studies.

Authors: 
Journal:  Blood Press Monit       Date:  1997-12       Impact factor: 1.444

7.  [Arterial hypertension in the Baix Ebre region (Tarragona)].

Authors:  J Custodi; J L Llor; M Farrús; E Ribas; J Vilaseca; J L Zaera; J L Tellado; R Pou; J Espinás; L Alonso
Journal:  Aten Primaria       Date:  1989-03       Impact factor: 1.137

8.  Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study.

Authors:  F J Nieto; J Alonso; L E Chambless; M Zhong; M Ceraso; F J Romm; L Cooper; A R Folsom; M Szklo
Journal:  Arch Intern Med       Date:  1995-04-10

9.  The determinants of hypertension awareness, treatment, and control in an insured population.

Authors:  D H Stockwell; S Madhavan; H Cohen; G Gibson; M H Alderman
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

10.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.

Authors:  V L Burt; J A Cutler; M Higgins; M J Horan; D Labarthe; P Whelton; C Brown; E J Roccella
Journal:  Hypertension       Date:  1995-07       Impact factor: 10.190

View more
  5 in total

1.  [Can or should blood pressure be measured at pharmacy offices?].

Authors:  J Divisón; L Artigao; C Sanchis; F Alvarez; J Carbayo; L Carrión; E Martínez-Navarro
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

2.  Prevalence, awareness, treatment and control of hypertension in a working Bulgarian population.

Authors:  A D Stein; V Stoyanovsky; V Mincheva; E Dimitrov; D Hodjeva; A Petkov; V Tsanova
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

3.  Trends in prevalence, awareness, treatment, and control of hypertension, and the risk of mortality among middle-aged Lithuanian urban population in 1983-2009.

Authors:  Regina Reklaitiene; Abdonas Tamosiunas; Dalia Virviciute; Migle Baceviciene; Dalia Luksiene
Journal:  BMC Cardiovasc Disord       Date:  2012-08-31       Impact factor: 2.298

4.  Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China.

Authors:  Min Zhang; Yong Meng; Yongli Yang; Yancai Liu; Caiqin Dong; Jianming Xiao; Ling Zhao; Fang Li
Journal:  BMC Public Health       Date:  2011-05-11       Impact factor: 3.295

5.  Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe.

Authors:  Luis M Artigao-Rodenas; Julio A Carbayo-Herencia; Juan A Divisón-Garrote; Vicente F Gil-Guillén; Javier Massó-Orozco; Marta Simarro-Rueda; Francisca Molina-Escribano; Carlos Sanchis; Lucinio Carrión-Valero; Enrique López de Coca; David Caldevilla; Juan López-Abril; Concepción Carratalá-Munuera; Adriana Lopez-Pineda
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.